Why CAMP4?
Leadership
Investors
About Our Name
RAP Platform
Reg Actuators
Programmable Therapeutics
Publications & Presentations
Pipeline
Newsroom
Join the Adventure
Recent News
September 5, 2023
CAMP4 Therapeutics to Present at Upcoming Industry and Investor Conferences
Read More
March 21, 2024
CAMP4 Therapeutics Announces Dosing of First Participant in Phase 1 Clinical Study of CMP-CPS-001, a Potential First-in-Class Therapeutic for Urea Cycle Disorders
Read More
Contact Us
Privacy Policy
Menu
Newsroom
Views and missives from the frontier
All
Press Releases
Perspectives
In the News
Videos
May 31, 2018
In the News
Xconomy
CAMP4 Hauls in $30M to Map New Ground with Drug Discovery Tech
May 31, 2018
In the News
FierceBiotech
Startup debuts with plan to map gene signaling pathways for new targets
«
1
2
3
Media Contact:
PR@camp4tx.com
Top